Polygenic Scores and Mood Disorder Onsets in the Context of Family History and Early Psychopathology

Authors

Kathryn Freeman, Department of Medical Neuroscience, Dalhousie University, Halifax, Nova Scotia, Canada.
Alyson Zwicker, Nova Scotia Health Authority, Halifax, Nova Scotia, Canada.
Janice M. Fullerton, Neuroscience Research Australia, Randwick, New South Wales, Australia.
Danella M. Hafeman, Western Psychiatric Hospital, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
Neeltje E. van Haren, Department of Child and Adolescent Psychiatry/Psychology, Erasmus University Medical Center, Sophia Children's Hospital, Rotterdam, the Netherlands.
John Merranko, Western Psychiatric Hospital, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
Benjamin I. Goldstein, Centre for Addiction and Mental Health, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
Emma K. Stapp, Milken Institute School of Public Health, George Washington University, Washington, District of Columbia.
Elena de la Serna, Fundacio Clínic per la Recerca Biomedica, Institut d'Investigacions Biomèdiques d'August Pi i Sunye, Barcelona, Spain.
Dolores Moreno, Centro de Investigación Biomédica en Red de Salud Mental, Madrid, Spain.
Gisela Sugranyes, Fundacio Clínic per la Recerca Biomedica, Institut d'Investigacions Biomèdiques d'August Pi i Sunye, Barcelona, Spain.
Sergi Mas, Fundacio Clínic per la Recerca Biomedica, Institut d'Investigacions Biomèdiques d'August Pi i Sunye, Barcelona, Spain.
Gloria Roberts, Discipline of Psychiatry and Mental Health, School of Clinical Medicine, University of New South Wales, Randwick, New South Wales, Australia.
Claudio Toma, Neuroscience Research Australia, Randwick, New South Wales, Australia.
Peter R. Schofield, Neuroscience Research Australia, Randwick, New South Wales, Australia.
Howard J. Edenberg, Department of Biochemistry and Molecular Biology, Indiana University, Indianapolis.
Holly C. Wilcox, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Melvin G. McInnis, Department of Psychiatry, University of Michigan, Ann Arbor.
Lukas Propper, Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada.
Barbara Pavlova, Nova Scotia Health Authority, Halifax, Nova Scotia, Canada.
Samuel A. Stewart, Department of Community Health and Epidemiology, Dalhousie University, Halifax, Nova Scotia, Canada.
Eileen M. Denovan-Wright, Department of Pharmacology, Dalhousie University, Halifax, Nova Scotia, Canada.
Guy A. Rouleau, Montreal Neurological Institute and Department of Neurology, McGill University, Montreal, Quebec, Canada.
Josefina Castro-Fornieles, Fundacio Clínic per la Recerca Biomedica, Institut d'Investigacions Biomèdiques d'August Pi i Sunye, Barcelona, Spain.
Manon H. Hillegers, Department of Child and Adolescent Psychiatry/Psychology, Erasmus University Medical Center, Sophia Children's Hospital, Rotterdam, the Netherlands.
Boris Birmaher, Western Psychiatric Hospital, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
Philip B. Mitchell, Discipline of Psychiatry and Mental Health, School of Clinical Medicine, University of New South Wales, Randwick, New South Wales, Australia.
Martin Alda, Nova Scotia Health Authority, Halifax, Nova Scotia, Canada.
John I. Nurnberger, Department of Psychiatry, Indiana University School of Medicine, Indianapolis.
Rudolf Uher, Department of Medical Neuroscience, Dalhousie University, Halifax, Nova Scotia, Canada.

Document Type

Journal Article

Publication Date

4-1-2025

Journal

JAMA network open

Volume

8

Issue

4

DOI

10.1001/jamanetworkopen.2025.5331

Abstract

IMPORTANCE: Bipolar disorder (BD) and major depressive disorder (MDD) aggregate within families, with risk often first manifesting as early psychopathology, including attention-deficit/hyperactivity disorder (ADHD) and anxiety disorders. OBJECTIVE: To determine whether polygenic scores (PGS) are associated with mood disorder onset independent of familial high risk for BD (FHR-BD) and early psychopathology. DESIGN, SETTING, AND PARTICIPANTS: This cohort study used data from 7 prospective cohorts enriched in FHR-BD from Australia, Canada, the Netherlands, Spain, and the US. Participants with FHR-BD, defined as having at least 1 first-degree relative with BD, were compared with participants without FHR for any mood disorder. Participants were repeatedly assessed with variable follow-up intervals from July 1992 to July 2023. Data were analyzed from August 2023 to August 2024. EXPOSURES: PGS indexed genetic liability for MDD, BD, anxiety, neuroticism, subjective well-being, ADHD, self-regulation, and addiction risk factor. Semistructured diagnostic interviews with relatives established FHR-BD. ADHD or anxiety disorder diagnoses before mood disorder onset constituted early psychopathology. MAIN OUTCOMES AND MEASURES: The outcome of interest, mood disorder onset, was defined as a consensus-confirmed new diagnosis of MDD or BD. Cox regression examined associations of PGS, FHR-BD, ADHD, and anxiety with mood disorder onset. Kaplan-Meier curves and log-rank tests evaluated the probability of onset by PGS quartile and familial risk status. RESULTS: A total of 1064 participants (546 [51.3%] female; mean [SD] age at last assessment, 21.7 [5.1] years), including 660 with FHR-BD and 404 without FHR for any mood disorder, were repeatedly assessed for mental disorders. A total of 399 mood disorder onsets occurred over a variable mean (SD) follow-up interval of 6.3 (5.7) years. Multiple PGS were associated with onset after correcting for FHR-BD and early psychopathology, including PGS for ADHD (hazard ratio [HR], 1.19; 95% CI, 1.06-1.34), self-regulation (HR, 1.19; 95% CI, 1.06-1.34), neuroticism (HR, 1.18; 95% CI, 1.06-1.32), MDD (HR, 1.17; 95% CI, 1.04-1.31), addiction risk factor (HR, 1.16; 95% CI, 1.04-1.30), anxiety (HR, 1.15; 95% CI, 1.02-1.28), BD (HR, 1.14; 95% CI, 1.02-1.28), and subjective well-being (HR, 0.89; 95% CI, 0.79-0.99). High PGS for addiction risk factor, anxiety, BD, and MDD were associated with increased probability of onset in the control group. High PGS for ADHD and self-regulation increased rates of onset among participants with FHR-BD. PGS for self-regulation, ADHD, and addiction risk factors showed stronger associations with onsets of BD than MDD. CONCLUSIONS AND RELEVANCE: In this cohort study, multiple PGS were associated with mood disorder onset independent of family history of BD and premorbid diagnoses of ADHD or anxiety. The association between PGS and mood disorder risk varied depending on family history status.

Department

Epidemiology

Share

COinS